DiaMedica Therapeutics Inc.DMACNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-12.81%
↓ 17% below average
Average (39q)
-10.96%
Historical baseline
Range
High:151.45%
Low:-298.02%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -12.81% |
| Q2 2025 | 1.68% |
| Q1 2025 | 3.27% |
| Q4 2024 | -22.32% |
| Q3 2024 | -22.08% |
| Q2 2024 | 1.79% |
| Q1 2024 | 1.83% |
| Q4 2023 | -13.40% |
| Q3 2023 | -8.77% |
| Q2 2023 | 14.13% |
| Q1 2023 | -38.96% |
| Q4 2022 | -27.01% |
| Q3 2022 | 7.02% |
| Q2 2022 | 4.86% |
| Q1 2022 | -8.93% |
| Q4 2021 | 4.98% |
| Q3 2021 | -1.52% |
| Q2 2021 | 7.02% |
| Q1 2021 | 15.21% |
| Q4 2020 | -28.59% |
| Q3 2020 | -22.56% |
| Q2 2020 | -12.65% |
| Q1 2020 | 13.21% |
| Q4 2019 | -4.10% |
| Q3 2019 | 2.92% |
| Q2 2019 | 19.88% |
| Q1 2019 | -102.79% |
| Q4 2018 | -18.86% |
| Q3 2018 | 27.24% |
| Q2 2018 | -298.02% |
| Q1 2018 | 57.87% |
| Q4 2017 | -261.50% |
| Q3 2017 | -34.45% |
| Q2 2017 | -14.99% |
| Q1 2017 | 112.54% |
| Q4 2016 | -36.85% |
| Q3 2016 | 74.42% |
| Q2 2016 | 48.57% |
| Q1 2016 | -17.13% |
| Q4 2015 | 151.45% |